Infectious disease diagnostics and differentiation of viral VS. Bacterial infections for point of care applications (phase III)
Ended Definitive Contract Awarded Last action
- Contract number
- HDTRA124C0003
- Awardee
-
Genecapture, Inc. UEI LVKCTP3NJ1K1
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $3,492,904
Award facts
- Contract value 77% obligated
-
- $3,492,904.27 Current, with exercised options
- $4,541,420.24 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Huntsville, AL 35806, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $490,339 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,002,565 | |
| Other Administrative Action | $0 | |
| Original award | $2,000,000 |
About this award
The Defense Threat Reduction Agency awarded a $4.54 million definitive contract to Genecapture, Inc. on November 3, 2023, for infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications under a Phase III effort.
The contract is priced on a cost-plus-fixed-fee basis with a ceiling value of $4,541,420.24 and an ultimate completion date of July 31, 2026. Place of performance is Huntsville, AL. The effort advances Genecapture's CAPTURE technology platform, which identifies genetic signatures of pathogens to enable rapid diagnostic identification and antibiotic susceptibility testing in military and medical operational environments.
Quick answers
Who was awarded contract HDTRA124C0003?
HDTRA124C0003 was awarded to Genecapture, Inc. by Defense Threat Reduction Agency (Department of Defense) on November 3, 2023.
How much is contract HDTRA124C0003 worth?
The government has obligated $3,492,904 on HDTRA124C0003. Its potential value, with all options, is $4,541,420.
Was contract HDTRA124C0003 competed?
The extent of competition for HDTRA124C0003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award